# Enanta (ENTA) — News

ENTA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/enta/news

## Recent headlines

- [Epiroc AB: Barclays raises target price to SEK 285 from SEK 280](https://www.ainvest.com/news/epiroc-ab-barclays-raises-target-price-sek-285-sek-280-2610) — AInvest Wire, Oct 14, 2026
  Barclays has raised its target price for Epiroc AB (EPI.A) to SEK 285 from SEK 280, reflecting the firm’s confidence in the company’s operational performance and market positioning. The adjustment, while modest, underscores the analyst’s view of Epiroc’s strong fundamentals and continued growth in…
- [Entain - BetMGM targets adj EBITDA of $500 mln in coming years](https://www.ainvest.com/news/entain-betmgm-targets-ebitda-500-mln-coming-years-2610) — AInvest Wire, Oct 13, 2026
- [Entain - BetMGM Q3 2026 IGaming net revenue $483 mln, online sports net revenue $216 mln](https://www.ainvest.com/news/entain-betmgm-q3-2026-igaming-net-revenue-483-mln-online-sports-net-revenue-216-mln-2610) — AInvest Wire, Oct 13, 2026
- [Enanta 3Q loss/share 67c, est. loss/share 46c](https://www.ainvest.com/news/enanta-3q-loss-share-67c-est-loss-share-46c-2608) — AInvest Wire, Aug 10, 2026
- [Enanta Pharmaceuticals: on track to report topline data from Phase 1 trial of EDP-978 in 4Q 2026](https://www.ainvest.com/news/enanta-pharmaceuticals-track-report-topline-data-phase-1-trial-edp-978-4q-2026-2608) — AInvest Wire, Aug 10, 2026
  Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) announced that the first participant has been dosed in a Phase 1 clinical trial of EDP-978, an oral, once-daily KIT inhibitor in development for chronic urticaria and other mast cell-driven diseases. The Phase 1 trial is designed to evaluate the safety,…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).